FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Report: Monoclonal antibodies for dementia lack clear benefits, show risks
By
Kristen Fischer
Jan 23, 2024
Even though amyloid-reducing monoclonal antibodies (MABs) are on the market and some research shows they may treat Alzheimer’s disease and dementia, a new research review found there aren’t clear benefits...
Hurricanes hastened the deaths of adults with dementia, study finds
By
Alicia Lasek
Mar 08, 2023
People with Alzheimer’s and related dementias (ADRD) had higher mortality rates in U.S. counties that had recently experienced a hurricane disaster, investigators report.
Battle over Alzheimer’s drug coverage is hardly a no-brainer
By
John O'Connor
Feb 26, 2023
Well, it looks like we have a good old fashioned war of words developing over Alzheimer’s drug coverage. It’s a battle well worth watching.
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.
Researchers receive $47M grant to study Alzheimer’s disease
By
John Roszkowski
Sep 26, 2022
Researchers from the University of California, Irvine have been awarded a $47 million grant from the National Institute on Aging to develop animal models to study the biology behind Alzheimer’s disease.
Pay good providers more to care for dementia patients, researchers urge
By
Kimberly Marselas
Feb 09, 2023
Policymakers should consider incentivizing nursing homes to take patients with Alzheimer’s disease and related dementias, argue the authors of a new study that finds such patients currently are more...
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.